Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen or tumour derived synthetic peptides

Background: MHC class I-peptide tetramers are currently utilised to characterize CD8(+) T cell responses at single cell level. The generation and use of MHC class II tetramers to study antigen-specific CD4(+) T cells appears less straightforward. Most MHC class II tetramers are produced with a homogeneously built-in peptide, reducing greatly their flexibility of use. We attempted the generation of empty functional HLA-DR* 1101 tetramers, receptive for loading with synthetic peptides by incubation. No such reagent is in fact available for this HLA-DR allele, one of the most frequent in the Caucasian population. Results: We compared soluble MHC class II-immunoglobulin fusion proteins (HLA-DR* 1101-Ig) with soluble MHC class II protein fused with an optimised Bir site for enzymatic biotynilation (HLA-DR* 1101-Bir), both produced in insect cells. The molecules were multimerised by binding fluorochrome-protein A or fluorochrome- streptavidin, respectively. We find that HLA-DR* 1101Bir molecules are superior to the HLA-DR* 1101-Ig ones both in biochemical and functional terms. HLA-DR* 1101-Bir molecules can be pulsed with at least three different promiscuous peptide epitopes, derived from Tetanus Toxoid, influenza HA and the tumour associated antigen MAGE-3 respectively, to stain specific CD4(+) T cells. Both staining temperature and activation state of CD4(+) T cells are critical for the binding of peptide-pulsed HLA- DR*1101-Bir to the cognate TCR. Conclusion: It is therefore possible to generate a soluble recombinant HLA- DR*1101 backbone that is receptive for loading with different peptides to stain specific CD4(+) T cells. As shown for other HLA-DR alleles, we confirm that not all the strategies to produce soluble HLA-DR*1101 multimers are equivalent.